Table 2. Univariate and multivariate analysis for recurrence and OS by Cox regression models.
Parameter | Univariate Analysis | Multivariate Analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Predictor: recurrence | ||||||
Age(>60 years) | 1.17 | 1.08–2.11 | 0.017 | 1.13 | 1.04–1.96 | 0.027 |
Sex (male) | 0.83 | 0.50–2.11 | 0.713 | — | ||
Cause(HBV) | 1.64 | 0.95–2.87 | 0.076 | — | ||
Viral status | 2.30 | 1.20–4.21 | 0.011 | 2.01 | 1.09–4.09 | 0.029 |
Tumor number | 1.29 | 1.02–2.31 | 0.673 | — | ||
Tumor size | 1.78 | 1.31–3.24 | 0.021 | 1.54 | 1.24–2.91 | 0.038 |
Venous invasion | 2.11 | 1.49–4.99 | <0.001 | 1.87 | 1.32–3.06 | 0.002 |
TNM stage | 3.23 | 1.46–7.32 | 0.001 | 2.08 | 1.22–4.15 | 0.006 |
Child-Pugh class | 2.21 | 1.66–4.87 | <0.001 | 2.01 | 1.51–4.31 | <0.001 |
Presence of PVT | 3.55 | 2.62–4.87 | <0.001 | 1.78 | 1.21–2.65 | 0.003 |
Presence of extrahepatic | 4.04 | 3.01–5.77 | <0.001 | 1.85 | 1.28–2.62 | 0.001 |
AFP(>20 ng/ml) | 2.07 | 1.42–3.01 | 0.008 | 1.88 | 1.27–3.98 | 0.011 |
Hs-CRP(>0.4 mg/dl) | 2.18 | 1.71–4.45 | <0.001 | 1.79 | 1.36–3.39 | 0.008 |
TrxRa | 10.23 | 4.14–30.76 | <0.001 | 4.19 | 3.21–7.08 | <0.001 |
Predictor: OS | ||||||
Age(>60 years) | 1.69 | 1.34–3.04 | 0.019 | 1.44 | 1.13–2.56 | 0.036 |
Sex (male) | 0.69 | 0.35–1.34 | 0.241 | — | ||
Cause(HBV) | 1.54 | 1.06–3.21 | 0.097 | — | ||
Viral status | 1.24 | 1.07–3.32 | 0.332 | — | ||
Tumor number | 1.42 | 1.02–1.98 | 0.110 | — | ||
Tumor size | 1.99 | 1.25–4.09 | 0.012 | 1.79 | 1.18–3.04 | 0.018 |
Venous invasion | 2.11 | 1.49–3.59 | <0.001 | 1.57 | 1.21–2.87 | 0.002 |
TNM stage | 2.24 | 1.22–4.02 | <0.001 | 2.11 | 1.42–3.29 | 0.001 |
Child-Pugh class | 2.06 | 1.42–2.91 | <0.001 | 2.00 | 1.55–4.26 | <0.001 |
Presence of PVT | 3.95 | 2.90–5.23 | <0.001 | 1.66 | 1.08–2.75 | 0.022 |
Presence of extrahepatic | 3.05 | 2.22–4.19 | <0.001 | 1.62 | 1.13–2.26 | 0.008 |
AFP(>20 ng/ml) | 2.19 | 1.09–4.32 | 0.028 | 1.94 | 1.10–3.77 | 0.038 |
Hs-CRP(>0.4 mg/dl) | 3.06 | 1.66–5.63 | <0.001 | 2.49 | 1.54–4.06 | <0.001 |
TrxRa | 16.15 | 6.11–39.65 | <0.001 | 5.56 | 3.42–10.21 | <0.001 |
increase per log unit(thus, a log-transformed increase of 1 corresponds to a TrxR increase of 10 U/mL)
OS = Overall survival; CI = confidence intervals; HR = hazard ratios; HBV = hepatitis B virus; PVT = portal vein thrombosis; AFP = α-fetoprotein; Hs-CRP = High-sensitivity-C-reactive protein; TrxR = Thioredoxin reductase.